Trademark: 88811294
Status Date
Monday, March 18, 2024
Filing Date
Wednesday, February 26, 2020
Published for Opposition
Tuesday, December 22, 2020
Abandoned Date
Monday, March 18, 2024
5 Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for immunotherapy through genetically engineered cell therapy; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of cancer and tumors for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of immune disorders for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of cancer and tumors for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of immune disorders for medical or clinical purposes; biological and pharmaceutical preparations for the treatment of cancer and immune disorders using genetically engineered cells
35 Business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of cancer and tumors; business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of immune disorders; pharmaceutical sales promotion for others
42 Pharmaceutical research and development; medical and scientific research and development of cellular immunotherapies for the treatment of cancer and tumors; medical and scientific research and development of cellular immunotherapies for the treatment of immune disorders; conducting clinical trials for others regarding pharmaceutical preparations and drugs in the field of immunotherapy and cell therapy; scientific and technological services, namely, research, analysis, and clinical trials for others in the field of cellular immunotherapy; providing medical and scientific research information in the field of cellular immunotherapies; compiling scientific and or clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of cell therapy, genetics, immunology, rare diseases, and oncology; licensing of technology in the fields of pharmaceuticals and gene therapy
Mar 18, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 18, 2024
Abandonment - No Use Statement Filed
Aug 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2023
Sou Extension 5 Granted
Jul 24, 2023
Sou Extension 5 Filed
Jul 24, 2023
Sou Teas Extension Received
Mar 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 8, 2023
Sou Extension 4 Granted
Feb 16, 2023
Sou Extension 4 Filed
Mar 3, 2023
Case Assigned To Intent To Use Paralegal
Feb 16, 2023
Sou Teas Extension Received
Aug 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2022
Sou Extension 3 Granted
Jul 31, 2022
Sou Extension 3 Filed
Jul 31, 2022
Sou Teas Extension Received
Apr 25, 2022
Teas Change Of Correspondence Received
Apr 25, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 25, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2022
Sou Extension 2 Granted
Feb 15, 2022
Sou Extension 2 Filed
Feb 15, 2022
Sou Teas Extension Received
Aug 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2021
Sou Extension 1 Granted
Aug 11, 2021
Sou Extension 1 Filed
Aug 11, 2021
Sou Teas Extension Received
Jun 1, 2021
Teas Change Of Correspondence Received
Jun 1, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 1, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 16, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 10, 2021
Teas Change Of Correspondence Received
Feb 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 22, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 22, 2020
Published For Opposition
Dec 2, 2020
Notification Of Notice Of Publication E-Mailed
Nov 13, 2020
Approved For Pub - Principal Register
Nov 13, 2020
Examiner's Amendment Entered
Nov 13, 2020
Notification Of Examiners Amendment E-Mailed
Nov 13, 2020
Examiners Amendment E-Mailed
Nov 13, 2020
Examiners Amendment -Written
Nov 12, 2020
Teas/Email Correspondence Entered
Nov 11, 2020
Correspondence Received In Law Office
Nov 11, 2020
Teas Response To Office Action Received
May 15, 2020
Notification Of Non-Final Action E-Mailed
May 15, 2020
Non-Final Action E-Mailed
May 15, 2020
Non-Final Action Written
May 15, 2020
Assigned To Examiner
Mar 7, 2020
New Application Office Supplied Data Entered
Mar 5, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
